Thus, the inconsistent results of the NAT2 acetylation status and bladder cancer risk from epidemiological studies in different races could be the results of different prevalence of genetic variants in the NAT2 gene and different levels of exposure to tobacco and other environmental bladder carcinogens. Here, NAT2 is linked to urinary bladder carcinoma.